Bin Jiang

4.9k total citations
94 papers, 1.7k citations indexed

About

Bin Jiang is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Bin Jiang has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Hematology, 30 papers in Molecular Biology and 26 papers in Genetics. Recurrent topics in Bin Jiang's work include Acute Myeloid Leukemia Research (45 papers), Chronic Myeloid Leukemia Treatments (28 papers) and Acute Lymphoblastic Leukemia research (22 papers). Bin Jiang is often cited by papers focused on Acute Myeloid Leukemia Research (45 papers), Chronic Myeloid Leukemia Treatments (28 papers) and Acute Lymphoblastic Leukemia research (22 papers). Bin Jiang collaborates with scholars based in China, United States and United Kingdom. Bin Jiang's co-authors include Xiao‐Jun Huang, Yanrong Liu, Shanshan Chen, Kai‐Yan Liu, Ya‐Zhen Qin, Qian Jiang, Hao Jiang, Hong‐Hu Zhu, Kevin Lu and Yue‐Yun Lai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bin Jiang

90 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Jiang China 21 1.2k 709 365 330 299 94 1.7k
Rory M. Shallis United States 19 1.3k 1.1× 742 1.0× 381 1.0× 442 1.3× 265 0.9× 109 1.8k
Vishal Kukreti Canada 24 1.4k 1.2× 1.3k 1.8× 967 2.6× 454 1.4× 96 0.3× 207 2.4k
Stephen Schey United Kingdom 20 1.1k 1.0× 677 1.0× 894 2.4× 218 0.7× 161 0.5× 71 1.8k
Marinus van Marwijk Kooy Netherlands 23 2.1k 1.8× 843 1.2× 658 1.8× 375 1.1× 605 2.0× 44 2.6k
Archie Prentice United Kingdom 19 772 0.7× 420 0.6× 380 1.0× 394 1.2× 332 1.1× 55 1.7k
Jae Hoon Lee South Korea 27 1.2k 1.0× 851 1.2× 1.0k 2.8× 570 1.7× 164 0.5× 162 2.4k
Atul Sharma India 21 486 0.4× 481 0.7× 568 1.6× 262 0.8× 161 0.5× 176 1.7k
Thomas S. McConnell United States 15 897 0.8× 646 0.9× 631 1.7× 200 0.6× 371 1.2× 26 1.6k
Elliott F. Winton United States 23 1.4k 1.2× 841 1.2× 454 1.2× 1.2k 3.8× 208 0.7× 81 2.5k
Åsa Rangert Derolf Sweden 19 2.2k 1.9× 1.2k 1.7× 525 1.4× 1.2k 3.5× 613 2.1× 42 2.8k

Countries citing papers authored by Bin Jiang

Since Specialization
Citations

This map shows the geographic impact of Bin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Jiang more than expected).

Fields of papers citing papers by Bin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Jiang. The network helps show where Bin Jiang may publish in the future.

Co-authorship network of co-authors of Bin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Jiang. A scholar is included among the top collaborators of Bin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Jiang. Bin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Yiran, Siyu Liu, Han Xiao, et al.. (2025). Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia. Journal of Health Population and Nutrition. 44(1). 96–96.
4.
Wang, Jianxiang, Bin Jiang, Li J, et al.. (2024). Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia. Leukemia. 38(11). 2410–2418. 2 indexed citations
5.
Wang, Jianxiang, Bin Jiang, Li J, et al.. (2021). Gilteritinib Versus Salvage Chemotherapy for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: A Phase 3, Randomized, Multicenter, Open-Label Trial in Asia. Blood. 138(Supplement 1). 695–695. 5 indexed citations
7.
Zhao, Ting, Hua Jiang, Jianwei Lu, et al.. (2017). [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].. PubMed Central. 38(1). 10–16. 3 indexed citations
8.
Zhu, Hong‐Hu, Jinsong Jia, Qian Jiang, et al.. (2017). Determinants of Early Death and Outcomes for Acute Promyelocytic Leukemia in the Arsenic Era: A Real World Study. Blood. 130. 1340–1340. 1 indexed citations
9.
Wang, Jing, Qian Jiang, Lan‐Ping Xu, et al.. (2017). Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 24(4). 741–750. 34 indexed citations
10.
Jiang, Bin, Kai‐Yan Liu, Lan‐Ping Xu, et al.. (2015). [Outcome of patients with adult acute lymphoblastic leukemia between 2000 and 2013: experience from single center].. PubMed. 36(9). 726–32. 4 indexed citations
11.
Zhang, Yao, Bao Li, Jin Lu, et al.. (2014). The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma. Molecular Cancer. 13(1). 25–25. 8 indexed citations
12.
Jiang, Bin, et al.. (2013). Development and application of a loop-mediated isothermal amplification assay for visual detection of Haemophilus parasuis.. Journal of Northwest A&F University. 41(12). 61–66. 1 indexed citations
14.
Chen, Shaoying, Xiaoxia Cheng, Fengqiang Lin, et al.. (2011). Establishment and its application of RT-PCR for detection of novel duck reovirus.. Journal of Pharmaceutical and Biomedical Sciences. 19(2). 388–392. 3 indexed citations
15.
Shi, Shaohua, et al.. (2010). Detection of duck circovirus infection.. 32(1). 31–33. 1 indexed citations
16.
Mateos, María‐Victoria, Paul G. Richardson, Rudolf Schlag, et al.. (2010). Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial. Journal of Clinical Oncology. 28(13). 2259–2266. 312 indexed citations
17.
Zhang, Linsheng, et al.. (2009). Cloning and sequence analysis of a new dehydrin gene (WZY2) from wheat.. Journal of Northwest A&F University. 37(2). 93–99. 6 indexed citations
18.
Jiang, Bin, Qian Jiang, Yan Zhang, et al.. (2008). Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant. Acta Haematologica. 120(3). 146–149. 3 indexed citations
19.
Zhu, Hong‐Hu, et al.. (2007). Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.. PubMed. 120(20). 1803–8. 5 indexed citations
20.
Lin, Fengqiang, Shaoying Chen, Xiaoli Zhu, et al.. (2004). Detection of muscovy duck reovirus by RT-PCR. Zhongguo shouyi xuebao. 24(3). 231–232. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026